Overnight: AI Startups Devour 41% of VC as Market Splits Into 'K-Shaped' Reality
AI startups just consumed a staggering 41% of all venture capital dollars in 2025, vacuuming up $52.5 billion of the $128 billion raised by companies ...
AI startups just consumed a staggering 41% of all venture capital dollars in 2025, vacuuming up $52.5 billion of the $128 billion raised by companies ...
BREAKING NEWS — In a move that signals the pharmaceutical industry's full-scale embrace of artificial intelligence, Swiss healthcare giant Roche has ...
🔥 BREAKING: NVIDIA just dropped the mic at GTC 2026 with projections that would make even Wall Street blush. CEO Jensen Huang announced the company expects $1 TRILLION in orders for Blackwell and ...
The Pentagon opened GenAI.mil to 3 million personnel with ChatGPT Mil and Grok for Government at IL5 clearance. Anthropic's Claude is the one vendor left out.
🔥 Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems — the most prominent challenger to Nvidia's GPU empire — hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash — about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA cleared Revolution Medicines' daraxonrasib, the first broad RAS-targeted pill for metastatic pancreatic cancer, doubling median survival to 13.2 months at a $477,000-a-year list price.
The FDA cleared GENGLYCOS, Ultragenyx's first gene therapy: a one-time $2.7 million infusion targeting the root cause of glycogen storage disease type Ia.
AusperBio raised $120M to push AHB-137, an antisense drug that cleared hepatitis B in 68% of a small trial, toward the first functional cure for a disease 240 million people live with.